Astellas launches new bladder treatment in Britain - (The Asahi Shimbun via NewsPoints Desk)

  • Astellas said that its European subsidiary, Astellas Pharma Europe, is offering Betmiga (mirabegron) in the UK for the treatment of an overactive bladder, The Asahi Shimbun reported on Wednesday.
  • The once-daily therapy that relaxes the bladder muscle and thereby reduces the urge to visit the bathroom, the company said.
  • The company added that the condition affects around 7 million adults in the UK.

To read more NewsPoints articles, click here.

Reference Articles